Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K180452
    Date Cleared
    2018-06-12

    (112 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The White Nitrile Examination Glove,Sterile, is a disposable device intended for medical purposes that is worn on the examiner Is hand or finger to prevent contamination between patient and examiner. In addition these gloves were tested for use with Chemotherapy drugs in accordance with ASTM D6978-05 standards: Practice for assessment of Medical Glove to Permeation by chemotherapy Drugs

    Device Description

    The subject device in this 510(k) Notification is White Nitrile Examination Gloves Sterile with tested for use with Chemotherapy drugs claims. The subject device is a patient examination glove made from nitrile latex compound, White color, powder free and sterile (Per 21 CFR 880.6250, class I). The White Nitrile Examination Glove ,Sterile, is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner (product Code LZA) and is used with chemotherapy drugs (Product code LZC).

    AI/ML Overview

    The provided document is a 510(k) Premarket Notification for a medical device: "White Nitrile Examination Glove, Sterile Tested for use with Chemotherapy Drugs Claim." It outlines the acceptance criteria for the glove's performance, particularly its resistance to chemotherapy drugs, and summarizes the non-clinical testing performed.

    Here's a breakdown of the requested information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The primary acceptance criteria for the chemotherapy drug resistance claim are defined by ASTM D6978-05 standards: Practice for assessment of Medical Glove to Permeation by chemotherapy Drugs. The device's performance is reported as the "Minimum Breakthrough detection time in minutes." The acceptance criteria are implicit in the comparison to the predicate device and the standard, aiming for breakthrough times that prevent drug permeation for a reasonable duration of use. The reported "Minimum Breakthrough detection time" for most drugs is "> 240 Minutes", indicating that no permeation was detected within the maximum test duration.

    Chemotherapy Drugs and ConcentrationAcceptance Criteria (Implicit)Reported Device Performance (Minimum Breakthrough detection time in minutes, 0.01 µg/cm2/minute)
    Carmustine (BCNU) (3.3 mg/ml)Adequate time to prevent permeation during anticipated use17.1 Minutes
    Cyclophosphamide (20 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes
    Cisplatin (1.0 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes (from table on page 2)
    Dacarbazine (DTIC) (10 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes (from table on page 2)
    Doxorubicin Hydrochloride (2.0 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes
    Etoposide (20 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes
    Fluorouracil (50 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes
    Paclitaxel (6.0 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes
    Thiotepa (10 mg/ml)Adequate time to prevent permeation during anticipated use55.9 minutes
    Cytarabine (10 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes (from table on page 4)
    Methotrexate (25 mg/ml)Adequate time to prevent permeation during anticipated use> 240 Minutes (from table on page 4)

    Other acceptance criteria and performance related to the general glove properties (ASTM D6319-10 Standard specification for Nitrile Examination Gloves) and Biological Evaluation on medical device:

    PropertyAcceptance CriteriaReported Device Performance
    Tensile Strength (MPa) - Before Ageing14 min14 min
    Ultimate Elongation (%) - Before Ageing500 min500 min
    Tensile Strength (MPa) - After Ageing14 min14 min
    Ultimate Elongation (%) - After Ageing400 min400 min
    Pin-hole LevelAQL 2.5 Inspection Level G-1Meets ASTM D6319-10 (AQL 2.5 Inspection Level G-1 via ASTM D5151-06)
    Residual Powder<2.0 mg/pcMeets ASTM D6124-06 (<2.0 mg/pc)
    Overall Length (mm)Min 230 mmMeets ASTM D6319-10
    Width (± 5mm) - Size S85 mmMeets ASTM D6319-10
    Width (± 5mm) - Size M95 mmMeets ASTM D6319-10
    Width (± 5mm) - Size L105 mmMeets ASTM D6319-10
    Width (± 5mm) - Size XL115 mmMeets ASTM D6319-10
    Thickness at Palm (mm)Min 0.05 mmMeets ASTM D6319-10
    Thickness at Finger Tip (mm)Min 0.05 mmMeets ASTM D6319-10
    Primary Skin Irritation Test (ISO 10993-10)Non-irritantNon-irritant
    Dermal Sensitization Assay (ISO 10993-10)Non-sensitizerNon-sensitizer
    SterilitySterileSterile (Gamma Irradiation ISO 11137-2:2015)

    2. Sample size used for the test set and the data provenance

    The document does not explicitly state the specific sample size used for the chemotherapy drug permeation test set. However, it indicates that the testing was performed "in accordance with ASTM D6978-05 standards." This standard would dictate the sampling methodology and number of replicate tests required.

    The data provenance is not explicitly mentioned (e.g., country of origin of the testing lab), but it is a premarket notification from Riverstone Resources SDN BHD in Selangor, Malaysia. The testing would have been conducted by a laboratory to generate data for this submission. The nature of the studies (material property and drug permeation) implies prospective testing specifically for this device submission, not retrospective data.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This information is not applicable as the tests described are objective, laboratory-based analyses (material properties, drug permeation, biological evaluations) governed by established ASTM and ISO standards, rather than subjective evaluations requiring expert consensus or interpretation of images. The "ground truth" is determined by the results of these standardized physical and chemical tests.

    4. Adjudication method for the test set

    This information is not applicable for the reasons stated in point 3. The results are quantitative measurements against predefined thresholds in standards.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This is not applicable. The device is a physical examination glove, not an AI-powered diagnostic or assistive tool for human readers.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This is not applicable. The device is a physical examination glove, not an algorithm.

    7. The type of ground truth used

    The ground truth used for this device's evaluation is primarily based on:

    • Standardized Physical and Chemical Measurements: Adherence to ASTM D6319-10 (for general glove properties) and ASTM D6978-05 (for chemotherapy drug permeation), which involve objective measurements of tensile strength, elongation, dimensions, pinhole levels, residual powder, and breakthrough times.
    • Biological Evaluation Standards: Adherence to ISO 10993-10 for primary skin irritation and dermal sensitization, which are also standardized laboratory tests with objective endpoints.

    8. The sample size for the training set

    This information is not applicable. There is no "training set" in the context of physical medical device testing for properties like drug permeation and material strength. The device is not an AI model requiring a training phase.

    9. How the ground truth for the training set was established

    This information is not applicable for the reasons stated in point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1